Search research articles
Contact Us
Filters
Showing results (601-610 of 764) with videos related to
Page
of 77
Sort By:
Journal of the American College of Cardiology
|
June 25, 2011
Impact of insulin receptor substrate-1 genotypes on platelet reactivity and cardiovascular outcomes in patients with type 2 diabetes mellitus and coronary artery disease
Dominick J Angiolillo, Esther Bernardo, Martina Zanoni, et al.
TH Open : Companion Journal to Thrombosis and Haemostasis
|
December 30, 2020
Antiplatelet Therapy with Cangrelor in Patients Undergoing Surgery after Coronary Stent Implantation: A Real-World Bridging Protocol Experience
Roberta Rossini, Giulia Masiero, Claudia Fruttero, et al.
European Heart Journal. Cardiovascular Pharmacotherapy
|
November 25, 2023
Ticagrelor enhances the cardioprotective effects of ischemic preconditioning in stable patients undergoing percutaneous coronary intervention: the TAPER-S randomized study
Domenico D'Amario, Mattia Galli, Attilio Restivo, et al.
Circulation
|
February 8, 2021
Antithrombotic Therapy in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Undergoing Percutaneous Coronary Intervention: A North American Perspective: 2021 Update
Dominick J Angiolillo, Deepak L Bhatt, Christopher P Cannon, et al.
European Heart Journal. Cardiovascular Pharmacotherapy
|
March 30, 2022
Platelet P2Y12 inhibiting therapy in adjunct to vascular dose of rivaroxaban or aspirin: a pharmacodynamic study of dual pathway inhibition vs. dual antiplatelet therapy
Mattia Galli, Francesco Franchi, Fabiana Rollini, et al.
Circulation
|
February 16, 2026
Clopidogrel Versus Aspirin Monotherapy in Coronary Artery Disease: A Sex-Stratified Individual Patient Data Meta-Analysis of Randomized Trials
Felice Gragnano, Daniele Giacoppo, Ki Hong Choi, et al.
Thrombosis and Haemostasis
|
August 31, 2019
Effects of Edoxaban on the Cellular and Protein Phase of Coagulation in Patients with Coronary Artery Disease on Dual Antiplatelet Therapy with Aspirin and Clopidogrel: Results of the EDOX-APT Study
Francesco Franchi, Fabiana Rollini, Emilio Garcia, et al.
Circulation
|
December 7, 2007
Prasugrel compared with high loading- and maintenance-dose clopidogrel in patients with planned percutaneous coronary intervention: the Prasugrel in Comparison to Clopidogrel for Inhibition of Platelet Activation and Aggregation-Thrombolysis in Myocardial Infarction 44 trial
Stephen D Wiviott, Dietmar Trenk, Andrew L Frelinger, et al.
JACC. Cardiovascular Interventions
|
February 11, 2026
Genotype-Guided vs Conventional Oral P2Y<sub>12</sub> Inhibitors in Acute Coronary Syndrome: A Combined Analysis of TAILOR-PCI and POPular Genetics
Mattia Galli, Naveen L Pereira, Ryan J Lennon, et al.
Thrombosis and Haemostasis
|
January 4, 2022
Pharmacodynamic Profiles of Dual-Pathway Inhibition with or without Clopidogrel versus Dual Antiplatelet Therapy in Patients with Atherosclerotic Disease
Mattia Galli, Francesco Franchi, Fabiana Rollini, et al.
Page
of 77
Search research articles
Search
Showing results (601-610 of 764) with videos related to
Sort By:
Page
of 77
Journal of the American College of Cardiology
|
June 25, 2011
Impact of insulin receptor substrate-1 genotypes on platelet reactivity and cardiovascular outcomes in patients with type 2 diabetes mellitus and coronary artery disease
Dominick J Angiolillo, Esther Bernardo, Martina Zanoni, et al.
TH Open : Companion Journal to Thrombosis and Haemostasis
|
December 30, 2020
Antiplatelet Therapy with Cangrelor in Patients Undergoing Surgery after Coronary Stent Implantation: A Real-World Bridging Protocol Experience
Roberta Rossini, Giulia Masiero, Claudia Fruttero, et al.
European Heart Journal. Cardiovascular Pharmacotherapy
|
November 25, 2023
Ticagrelor enhances the cardioprotective effects of ischemic preconditioning in stable patients undergoing percutaneous coronary intervention: the TAPER-S randomized study
Domenico D'Amario, Mattia Galli, Attilio Restivo, et al.
Circulation
|
February 8, 2021
Antithrombotic Therapy in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Undergoing Percutaneous Coronary Intervention: A North American Perspective: 2021 Update
Dominick J Angiolillo, Deepak L Bhatt, Christopher P Cannon, et al.
European Heart Journal. Cardiovascular Pharmacotherapy
|
March 30, 2022
Platelet P2Y12 inhibiting therapy in adjunct to vascular dose of rivaroxaban or aspirin: a pharmacodynamic study of dual pathway inhibition vs. dual antiplatelet therapy
Mattia Galli, Francesco Franchi, Fabiana Rollini, et al.
Circulation
|
February 16, 2026
Clopidogrel Versus Aspirin Monotherapy in Coronary Artery Disease: A Sex-Stratified Individual Patient Data Meta-Analysis of Randomized Trials
Felice Gragnano, Daniele Giacoppo, Ki Hong Choi, et al.
Thrombosis and Haemostasis
|
August 31, 2019
Effects of Edoxaban on the Cellular and Protein Phase of Coagulation in Patients with Coronary Artery Disease on Dual Antiplatelet Therapy with Aspirin and Clopidogrel: Results of the EDOX-APT Study
Francesco Franchi, Fabiana Rollini, Emilio Garcia, et al.
Circulation
|
December 7, 2007
Prasugrel compared with high loading- and maintenance-dose clopidogrel in patients with planned percutaneous coronary intervention: the Prasugrel in Comparison to Clopidogrel for Inhibition of Platelet Activation and Aggregation-Thrombolysis in Myocardial Infarction 44 trial
Stephen D Wiviott, Dietmar Trenk, Andrew L Frelinger, et al.
JACC. Cardiovascular Interventions
|
February 11, 2026
Genotype-Guided vs Conventional Oral P2Y<sub>12</sub> Inhibitors in Acute Coronary Syndrome: A Combined Analysis of TAILOR-PCI and POPular Genetics
Mattia Galli, Naveen L Pereira, Ryan J Lennon, et al.
Thrombosis and Haemostasis
|
January 4, 2022
Pharmacodynamic Profiles of Dual-Pathway Inhibition with or without Clopidogrel versus Dual Antiplatelet Therapy in Patients with Atherosclerotic Disease
Mattia Galli, Francesco Franchi, Fabiana Rollini, et al.
Page
of 77